Preventing Injecting by Modifying Existing Responses (PRIMER)
PRIMER is a multi-country study on the impact of different interventions in preventing people who use drugs from initiating others into injection drug use.
Project Contents
Overview
PRIMER (Preventing Injecting by Modifying Existing Responses) is a multi-country mixed methods study with the aim of identifying whether specific interventions and factors influence the risk that individuals begin injecting drugs.
PRIMER pools qualitative and quantitative data from cohorts of people who use drugs across seven different cities: Vancouver, Canada; San Diego, USA; Tijuana, Mexico; Paris, Marseille, Bordeaux and Strasbourg, France.
PRIMER is the largest study of injection drug use initiation (n = 3,850) and is the first to examine structural responses to preventing injection initiation. Findings can potentially improve the development and scaling up of interventions to reduce transitions into injection drug use.
Financial Supporters
Canadian Institutes of Health Research
U.S. National Institute on Drug Abuse
Partners
British Columbia Centre on Substance Use, Vancouver, Canada | Centre hospitalier régional et universitaire, Strasbourg, France | Institut national de la santé et de la recherche médicale, Marseille, France | Université de Bordeaux, Bordeaux, France | Université René Descartes, Paris, France | University of California, San Diego, USA | University of Xochicalco, Tijuana, Mexico
Project Contact
Dan Werb